News
HBIO
--
0.00%
--
Harvard Bioscience (HBIO) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Harvard Bioscience (HBIO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks · 19h ago
Harvard Bioscience Schedules Third Quarter 2021 Earnings Conference Call for November 3, 2021 at 8:00 AM ET
Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for third quarter ended September 30, 2021, before the market opens on November 3, 2021, and will hold a conference call to discuss the results at 8:00 a.m. Eastern Time.
GlobeNewswire · 10/18 20:50
Is There An Opportunity With Harvard Bioscience, Inc.'s (NASDAQ:HBIO) 37% Undervaluation?
Today we will run through one way of estimating the intrinsic value of Harvard Bioscience, Inc. ( NASDAQ:HBIO ) by...
Simply Wall St. · 09/30 13:32
3 Medical Equipment Stocks Under $10 to Buy Now
StockNews.com · 09/17 10:41
Acuitas Investments, LLC Buys The Cato Corp, Meridian Bioscience Inc, Gatos Silver Inc, Sells ...
GuruFocus News · 08/25 13:38
Stocks That Hit 52-Week Highs On Friday
    During Friday's morning session, 137 companies made new 52-week highs.
Benzinga · 08/13 14:14
The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 12)
Benzinga · 08/13 11:43
BRIEF-Harvard Bioscience - On Aug 6, Court, With Regard To County Of Suffolk 2017 Complaint, Issued Ruling In Co's Favor, Vacating Sanctions
reuters.com · 08/09 21:42
Harvard Bioscience (HBIO) Tops Q2 Earnings and Revenue Estimates
Zacks.com · 08/05 13:05
Harvard Bioscience Announces Second Quarter 2021 Financial Results
Strong double digit revenue growth, solid margin performance despite global supply chain disruptions
GlobeNewswire · 08/05 11:00
-- Earnings Flash (HBIO) HARVARD BIOSCIENCE Posts Q2 Revenue $29.2M, vs. Street Est of $28M
MT Newswires · 08/05 07:23
-- Earnings Flash (HBIO) HARVARD BIOSCIENCE Reports Q2 EPS $0.06, vs. Street Est of $0.07
MT Newswires · 08/05 07:18
Acuitas Investments, LLC Buys Tilly's Inc, Meridian Bioscience Inc, InfuSystems Holdings Inc, ...
GuruFocus News · 08/02 18:38
Harvard Bioscience (HBIO) Reports Next Week: What to Know Ahead of the Release
Zacks.com · 07/29 04:31
What Type Of Shareholders Make Up Harvard Bioscience, Inc.'s (NASDAQ:HBIO) Share Registry?
The big shareholder groups in Harvard Bioscience, Inc. ( NASDAQ:HBIO ) have power over the company. Generally speaking...
Simply Wall St. · 07/20 08:30
Harvard Bioscience Schedules Second Quarter 2021 Earnings Conference Call for August 5, 2021 at 8:00 AM ET
Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for second quarter ended June 30, 2021 before the market opens on August 5, 2021, and will hold a conference call to discuss the results at 8:00 a.m. Eastern Time.
GlobeNewswire · 07/19 21:16
Insider Trends: Insider at Harvard Bioscience Sells for Tax Adds to 90-Day Selling Trend
MT Newswires · 07/12 17:10
10 Best Stocks Under $10 to Buy Right Now
In this article, we will be looking at the 10 best stocks under $10 to buy right now. If you want to skip our detailed analysis on these companies, you can go directly to the 5 Best Stocks Under $10 to Buy Right Now. Investing in cheap stocks can lead to f...
Insider Monkey · 07/12 12:49
Are You Looking for a Top Momentum Pick? Why Harvard Bioscience (HBIO) is a Great Choice
Zacks.com · 07/02 16:00
Webull provides a variety of real-time HBIO stock news. You can receive the latest news about Harvard through multiple platforms. This information may help you make smarter investment decisions.
About HBIO
Harvard Bioscience, Inc. is a developer, manufacturer, and seller of technologies, products and services that enable fundamental research, discovery, and preclinical testing for drug development. The Company provides products that support research in six different classes of laboratory use, including molecular, cellular, tissue, organ, organisms, and clinical. The Company primarily sells its products under several brand names, including Harvard Apparatus, DSI, Ponemah, Buxco, Biochrom, BTX, and MCS. The Company’s customers include pharmaceutical and biotechnology companies, as well as contract research organizations, academic labs, and government researchers.